Navigation Links
Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
Date:6/26/2012

New York City, NY (PRWEB) June 26, 2012

The Actos Resource Center, a patient advocacy group, is alerting patients who suffered injury after taking the diabetes drug Actos that certain Statutes of Limitation in their state could limit the amount of time they have to file a claim.

Anyone who has been diagnosed with bladder cancer or heart disease after taking the drug should consult with their doctor and contact a lawyer to learn about their legal options.

A little over a year ago on June 15, 2011, the FDA warned that Actos may be associated with a higher risk of bladder cancer. According to The Canadian Press on April 19, 2012, Health Canada joined the U.S., France, Germany and the European Medicines Agency in also issuing an Actos bladder cancer warning.

Hundreds of people have now contacted the Actos Resource Center to learn about their legal options after suffering bladder cancer, heart attacks or liver damage.

According to a Bloomberg report, Takeda faces thousands of Actos lawsuits from patients in the U.S. In an article published March 13, 2012, the news agency predicted as many as 10,000 patients may eventually file an Actos bladder cancer lawsuit.

However, victims who were prescribed Actos in a state with a one-year statute of limitations could face added legal challenges. According to lawyers with the Actos Resource Center, attorneys for Takeda Pharmaceuticals will likely argue that the deadline for victims in these states started on June 15, 2011 with the FDA warning and should expire a year later.

So far, no court has indicated that such cases would be barred, and a qualified lawyer can advise how long victims have to take action. However, since each case has a different expiration date, anyone affected is urged to seek help as soon as possible.

In December, a federal Judicial Panel on Multidistrict Litigation issued an order consolidating all lawsuits to a federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette)

The Actos Bladder Cancer Center only works with Actos lawyers who are actively involved in this litigation and have handled thousands of cases.

For more information on the research, actos warnings, side effects and legal options relating to the drug Actos, or to speak with a lawyer, visit http://www.ActosCancer.com.

Read the full story at http://www.prweb.com/releases/actos-bladder/cancer-lawsuit/prweb9640081.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
2. Brain-Injury Recovery Varies Widely Among Children
3. Substance Abusers, Even Recovering Ones, May Face Stigma
4. Recovery from propofol anesthesia may be sped by use of common stimulant
5. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
6. Surgical sling reduces risk of weakened bladder control after prolapse surgery, U-M study says
7. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
8. Study Ties Secondhand Smoke to Bladder Irritation in Kids
9. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
10. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
11. Chemo + Radiation Best for Bladder Cancer, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
Breaking Medicine Technology: